Tudor Investment Corp’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Tudor Investment Corp’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-72,687	Closed	-$6.55M	–	3976
2025 Q2	$6.03M	Sell	72,687 -74,404	-51%	-$5.94M	0.01%	976
2025 Q1	$11.9M	Buy	147,091 +72,307	+97%	+$6.46M	0.04%	391
2024 Q4	$6.74M	Buy	74,784 +19,307	+35%	+$1.87M	0.03%	541
2024 Q3	$5.48M	Buy	55,477 +38,122	+220%	+$3.75M	0.02%	661
2024 Q2	$1.61M	Sell	17,355 -94,527	-84%	-$8.48M	0.01%	1198
2024 Q1	$10.6M	Buy	111,882 +98,054	+709%	+$9.1M	0.07%	332
2023 Q4	$1.23M	Sell	13,828 -7,028	-34%	-$522K	0.01%	1349
2023 Q3	$1.52M	Buy	20,856 +3,427	+20%	+$274K	0.02%	1076
2023 Q2	$1.45M	Buy	+17,429	New	+$1.46M	0.02%	1082
2017 Q1	–	Sell	-325,000	Closed	-$19.2M	–	1579
2016 Q4	$19.2M	Buy	+325,000	New	+$20.1M	0.5%	29

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Tudor Investment Corp's XBI Position: Q3 2025 in Review

Tudor Investment Corp sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2025, closing a stake of 72,687 shares — an estimated $6.55M sold.

Tudor Investment Corp first reported a position in XBI in Q4 2016 and held it in 10 quarters. The position peaked at $19.2M in Q4 2016. 656 funds tracked by Wall St. Rank hold XBI as of Q3 2025.

Tudor Investment Corp reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2025 after selling out during the quarter.
Tudor Investment Corp sold 72,687 State Street SPDR S&P Biotech ETF shares in Q3 2025, an estimated $6.55M.
Tudor Investment Corp first reported a position in State Street SPDR S&P Biotech ETF in Q4 2016 and held it in 10 quarters.
Tudor Investment Corp's State Street SPDR S&P Biotech ETF position peaked at $19.2M in Q4 2016.
656 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2025.

Based on Tudor Investment Corp's 13F filing for Q3 2025, filed 14 Nov 2025.